Natalie Tellez, APRN
Psychiatric/Mental Health · Houston, TXNPI 1730433947
Payments from drug & device makers
Across 1,329 payments — averaging $453.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$435K
- Vanda Pharmaceuticals Inc.$115K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$41K
- Otsuka America Pharmaceutical, Inc.$9K
- Neurocrine Biosciences, Inc.$413
- Corium, LLC$377
- plus $2K from 16 others
What the payments were for
- Consulting fees$5,3251%
- Speaking & faculty fees$485,78581%
- Travel & lodging$91,69515%
- Food & beverage$19,3343%
- Education$380%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 876 | $434,643 |
| Vanda Pharmaceuticals Inc. | 195 | $114,986 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 107 | $40,726 |
| Otsuka America Pharmaceutical, Inc. | 53 | $9,274 |
| Neurocrine Biosciences, Inc. | 12 | $413 |
| Corium, LLC | 17 | $377 |
| Alkermes, Inc. | 13 | $364 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $296 |
| Lundbeck LLC | 10 | $251 |
| Axsome Therapeutics, Inc. | 6 | $226 |
| Bausch Health US, LLC | 6 | $130 |
| Johnson & Johnson | 5 | $128 |
| Teva Pharmaceuticals USA, Inc. | 5 | $93 |
| E.r. Squibb & Sons, L.L.C. | 3 | $62 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 2 | $57 |
| Tris Pharma Inc | 2 | $40 |
| Almatica Pharma LLC | 1 | $21 |
| Idorsia Pharmaceuticals US Inc | 1 | $20 |
| Noven Therapeutics, LLC | 1 | $19 |
| Lilly USA, LLC | 1 | $17 |
| Sunovion Pharmaceuticals Inc. | 1 | $17 |
| Neos Therapeutics, LP | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VRAYLAR$422,354
- Fanapt$112,616
- CAPLYTA$38,562
- LYBALVI$484
- REXULTI$483
- INGREZZA$127
- ABILIFY ASIMTUFII$124
- ABILIFY MAINTENA$124
- Azstarys$119
How this compares
$602,177 in reported general payments places this provider in the 95th percentile of 2,724 psychiatric/mental health providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| IngrezzaValbenazine Tosylate | 11 | $93,189 |
| Duloxetine Hcl | 65 | $2,513 |
| Bupropion XlBupropion Hcl | 48 | $1,448 |
| Quetiapine Fumarate | 69 | $1,150 |
| Ziprasidone Hcl | 18 | $797 |
| Trazodone Hcl | 61 | $767 |
| Clonazepam | 73 | $718 |
| Escitalopram Oxalate | 63 | $702 |
| Buspirone Hcl | 46 | $624 |
| Mirtazapine | 20 | $498 |
| Prazosin Hcl | 13 | $449 |
| Divalproex Sodium ErDivalproex Sodium | 18 | $444 |
| Aripiprazole | 19 | $384 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 15 | $379 |
| Lamotrigine | 31 | $329 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Neurocrine Biosciences, Inc.Ingrezza | $413 | $93,18911 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,724 psychiatric/mental health providers in Texas.
Other psychiatric/mental health in Houston
- Britney PridgenHouston$57K
- Linzi LeightonHouston$16K
- Samantha SharpeHouston$14K
- Jennifer RobinsonHouston$12K
- Tracy HicksLongview$684K
- Karah BrashierRichardson$567K
- Grant DavisRichardson$360K
- Victor IlogEl Paso$167K
- Lisa ShamblinGrapevine$163K
- Monique GonzalezSan Antonio$126K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.